Medpace Holdings, Inc. (MEDP) FCF Payout Ratio: N/A
The FCF payout ratio for Medpace Holdings, Inc. (MEDP) is N/A.
MEDP FCF Payout Ratio Metrics
FCF PAYOUT RATIO
N/A
Payout Ratio Comparison
FCF Payout Ratio
N/A
Earnings Payout Ratio
N/A
Dividend Yield
N/A
FCF Yield
5.52%
Annual FCF Payout Ratio History
| Year | Free Cash Flow | Dividends Paid | FCF Payout Ratio |
|---|---|---|---|
| 2025 | $681.87M | $0 | 0.0% |
| 2024 | $572.27M | $0 | 0.0% |
| 2023 | $396.73M | $0 | 0.0% |
| 2022 | $351.17M | $0 | 0.0% |
| 2021 | $235.06M | $0 | 0.0% |
| 2020 | $227.34M | $0 | 0.0% |
| 2019 | $183.96M | $0 | 0.0% |
| 2018 | $140.56M | $0 | 0.0% |
| 2017 | $85.09M | $0 | 0.0% |
| 2016 | $78.19M | $0 | 0.0% |
| 2015 | $79.41M | $0 | 0.0% |
| 2014 | $69.89M | $0 | 0.0% |
| 2013 | $93.58M | $0 | 0.0% |
Formula: FCF Payout Ratio = Dividends Paid / Free Cash Flow × 100
FCF payout and earnings payout:
- FCF represents operating cash flow after capital expenditures
- FCF payout compares dividends paid with free cash flow
- FCF payout above 100% means dividends paid exceeded free cash flow for the period
- Earnings payout compares dividends paid with net income
Reading the series: Use the chart and table to compare dividend payments with cash generation over time.
Medpace Holdings, Inc. FCF Payout Ratio Formula & Definition
FCF Payout Ratio measures what percentage of free cash flow is paid out as dividends. Unlike earnings-based payout, it compares dividends with cash generated after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
About Medpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- August James Troendle